Division of Medical Oncology, Windsor Regional Cancer Centre, Windsor, ON.
Curr Oncol. 2010 Aug;17(4):133-7. doi: 10.3747/co.v17i4.525.
Ductal carcinoma in situ (DCIS) in a young man is rarely reported. Our patient, a 25-year-old man, presented with apparent symptomatic unilateral gynecomastia. He has a strong history of cancer on both the maternal and paternal sides of his family, including breast and lung (maternal) and melanoma, colon, and pancreatic (paternal). His mother tested negative for BRCA1 and BRCA2. There is no information on paternal genetic testing.The patient was treated with left subcutaneous mastectomy. Upon histologic review of the sample, concurrent gynecomastia and DCIS were discovered. To date, only 4 cases of gynecomastia and DCIS have been described in younger male patients. Because only 30%-50% of patients with DCIS eventually develop invasive cancer in the subsequent 10-20 years, DCIS prevalence in the general population may be higher than predicted. This case underscores the importance of family history in any patient presenting with a breast mass. Patients must be made aware of the risk, however small it may be, and physicians must remain cautious of cancer in young men with gynecomastia.
男性导管原位癌(DCIS)很少见。我们的患者是一名 25 岁的男性,表现为明显的单侧症状性乳腺增生。他有强烈的家族癌症病史,包括母亲一方的乳腺癌和肺癌(母亲)和黑色素瘤、结肠癌和胰腺癌(父亲)。他的母亲 BRCA1 和 BRCA2 检测均为阴性。关于父亲的基因检测没有信息。该患者接受了左侧皮下乳房切除术。在对样本进行组织学检查时,发现同时存在乳腺增生和 DCIS。迄今为止,仅在年轻男性患者中描述了 4 例乳腺增生和 DCIS。由于只有 30%-50%的 DCIS 患者在随后的 10-20 年内最终发展为浸润性癌症,因此 DCIS 在普通人群中的患病率可能高于预期。该病例强调了任何出现乳房肿块的患者的家族史的重要性。必须告知患者风险,无论其风险有多小,并且医生必须对患有乳腺增生的年轻男性的癌症保持警惕。